Molecular determinants of Ca 2+ channel function and drug action

Author： Varadi G.   Mori Y.   Mikala G.   Schwartz A.  

Publisher： Elsevier

ISSN： 0165-6147

Source： Trends in Pharmacological Sciences, Vol.16, Iss.2, 1995-02, pp. : 43-49

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ca 2+ channel block and inactivation: common molecular determinants

By Hering S.   Berjukow S.   Aczel S.   Timin E.N.  

Trends in Pharmacological Sciences, Vol. 19, Iss. 11, 1998-11 ,pp. : 439-443

Elsevier

Access to resources Recommend Favorite

Halothane attenuates the cerebroprotective action of several Na + and Ca 2+ channel blockers via reversal of their ion channel blockade

By Oka M.   Itoh Y.   Fujita T.  

European Journal of Pharmacology, Vol. 452, Iss. 2, 2002-10 ,pp. : 175-181

Elsevier

Access to resources Recommend Favorite

Calcium Channel CaV1 Splice Isoforms - Tissue Specificity and Drug Action

By  

Current Molecular Pharmacology, Vol. 8, Iss. 1, 2015-01 ,pp. : 22-31

Bentham Science Publishers

Access to resources Recommend Favorite

Forskolin's structural analogue 1,9-dideoxyforskolin has Ca 2+ channel blocker-like action in rat cerebellar granule cells

By Zerr P.   Becherer U.   Rodeau J.-L.   Feltz A.  

European Journal of Pharmacology, Vol. 303, Iss. 1, 1996-05 ,pp. : 101-108

Elsevier

Access to resources Recommend Favorite

Cardiovascular action of a cardioselective Ca 2+ channel blocker AH-1058 in conscious dogs assessed by telemetry

By Takahara A.   Dohmoto H.   Yoshimoto R.   Sugiyama A.   Hashimoto K.  

European Journal of Pharmacology, Vol. 413, Iss. 1, 2001-02 ,pp. : 101-108

Elsevier

Access to resources Recommend Favorite